Cited by 583D Printing in Biomedical ResearchSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Vasculature-on-a-chip platform with innate immunity enables identification of angiopoietin-1 derived peptide as a therapeutic for SARS-CoV-2 induced inflammation

Open access
Lu, Rick Xing Ze, Lai, Benjamin Fook Lun, Rafatian, Naimeh, Gustafson, Dakota, Campbell, Scott B., Banerjee, Arinjay, Kozak, Robert, Mossman, Karen +4 more·2022·Lab on a Chip

Abstract

Microfluidic polymeric blood vessel captures the adverse effects of SARS-CoV-2 on vasculature and enables identification of a therapeutic peptide that abolished virus induced cytokine storm orchestrated by the immune cells.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1039/d1lc00817j

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Organoids and lung-on-a-chip models identified key COVID-19 mechanisms such as endothelial dysfunction, cytokine storm and variable infection susceptibility.

    “central pathomechanisms, such as the contribution of endothelial dysfunction, the ‘cytokine storm’ and the intercellular variability of infection susceptibility, were identified in organoids and lung-on-a-chip models82–86.”

    From Human disease models in drug development (2023) · cites this paper as [82]

    The Results and Discussion report endothelial barrier dysfunction and increased inflammatory cytokines after SARS-CoV-2 exposure, with PBMCs amplifying the response. But this study used a vasculature-on-a-chip, not an organoid or lung-on-a-chip, and it did not establish intercellular variability in infection susceptibility in those models. Page numbers are unavailable in our copy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • A vasculature-on-a-chip study found SARS-CoV-2 impairs endothelial barrier function by disrupting VE-cadherin junctions and raising pro-inflammatory cytokine release.

    “A vasculature-on-a-chip setup revealed that SARS-CoV-2 exposure substantially reduces endothelial barrier function by perturbing vascular endothelial–cadherin junctions and increasing pro-inflammatory cytokine release.”

    From Human disease models in drug development (2023) · cites this paper as [82]

  • Adding peripheral blood mononuclear cells worsens endothelial dysfunction and causes excessive inflammation.

    “This endothelial dysfunction is exacerbated after the introduction of peripheral blood mononuclear cells, resulting in excessive inflammation82.”

    From Human disease models in drug development (2023) · cites this paper as [82]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 13

  1. [16]Schimmel L, Yih K, Claudia C, Yordanov T, Essebier P, Kulasinghe A, Monkman J, Flavia A, Miggiolaro S, Lucia C,, bioRxiv 2021.
  2. [17]Mudd PA, Crawford JC, Turner JS, Souquette A, Reynolds D, Bender D, Bosanquet JP, Anand NJ, Striker DA, Martin RS,, Sci. Adv. 2020, 19, 1. PMC7725462 33187979
  3. [22]Munnink BBO, De Meulder D, Van Amerongen G, Van Den Brand J, Okba NMA, Schipper D, Van Run P, Leijten L, Sikkema R, Van Vlissingen MF,, Science (80-.). 2020, 1015, 1012.
  4. [23]Zhao L, Liu P, Zhao L, Ye F, Wang H, Zhou W, Zhu N, Zhen W, Wang X, Xiao Y,, Nature 2020, 583, 830.32380511
  5. [26]Fook B, Lai L, Xing R, Lu Z, Huyer LD, Kakinoki S, Yazbeck J, Wang EY, Wu Q, Zhang B,, Nat. Protoc. 2021, 16, 2158. 33790475
  6. [29]Paz NG, Amore PAD, 2014, 335, 5.
  7. [37]Lu RXZ, Lai BFL, Benge T, Wang EY, Davenport Huyer L, Rafatian N, Radisic M, Adv. Mater. Technol. 2020, 6, 1.
  8. [38]Weisser K, Ph D, Kyrle PA, Eichinger S, N. Engl. J. Med. 2021, 384, 2092. 33835769 PMC8095372
  9. [47]Junqueira C, Ranjbar S, Ingber J, Parry B, De Lacerda LB, Lewandrowski M, Clark S, Ho F, Setu M, Leger V,, medRxiv 2021, 1.
  10. [48]Codo AC, Davanzo GG, de B. Monteiro L, Nakaya HI, Farias AS, Moraes-vieira PM, Cell Metab. 2020, 32, 437.32697943
  11. [49]Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C,, N. Engl. J. Med. 2021, 384, 693.32678530
  12. [51]Aziz MS, Cooper N, Douglas IS, Savic S, Youngstein T, Del Sorbo L, Gracian AC, La Zerda DJD, Ustianowski A, Bao M,, N. Engl. J. Med. 2021, 384, 1503. 33631066 PMC7953459
  13. [61]Ma D, Vishal CC, Yuan CXX, Huang JLY, Tsz LC, Ng K, Eye 2020, 2, 1212.

Cited by

Sorted by citations

Authors
Lu, R. X. Z., Lai, B. F. L., Rafatian, N., Gustafson, D., Campbell, S. B., Banerjee, A., Kozak, R., Mossman, K., Mubareka, S., Howe, K. L., Fish, J. E., & Radisic, M.
Affiliations
  • University of Toronto (CA)
  • University Health Network (CA)
  • University of Saskatchewan (CA)
  • McMaster University (CA)
  • Sunnybrook Health Science Centre (CA)
Corresponding author
Radisic, Milica
Venue
Lab on a Chip
Published
2022
Volume
22
Issue
6
Pages
1171-1186
ISSN
  • 1473-0189 (ISSN-L)
  • 1473-0197
OpenAlex
W4210700717
Cited by
58
References
63
Citations by year
2026: 9 · 2025: 8 · 2024: 17 · 2023: 18 · 2022: 6
FWCI
3.56
Type
journal article
Language
en
Open access
Locations
  • Lab on a Chip (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Canadian Institutes of Health Research (FDN-167274)
  • Natural Sciences and Engineering Research Council of Canada (RGPIN 326982-10, ALLRP 5550)
  • National Institutes of Health (2R01 HL076485)
  • Connaught Fund
  • Killam Trusts
  • Canada Research Chairs
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords
SARS-CoV-2, COVID-19 pandemic, endothelial barrier dysfunction, innate immunity, peripheral blood mononuclear cells, inflammatory cytokines, angiopoietin-2, HCoV-NL63, endothelial dysfunction, hyperinflammation
MeSH terms
COVID-19, SARS-CoV-2, COVID-19 Drug Treatment, Endothelium, Vascular, Humans, Immunity, Innate, Inflammation, Leukocytes, Mononuclear, Angiopoietin-1, Endothelial Cells, Lab-On-A-Chip Devices

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review